Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient has confirmed partial onset seizures.~* Seizure activity is not adequately controlled by patient's current AED regimen.~* Patient is between 16 and 75 years of age.~* Patient is able to give accurate seizure counts and health outcomes information. Patient is able to complete study instruments with minimal assistance.~* Patient has previously failed at least 3 AEDs in single or combination use.~* During baseline evaluation period, patient should take at least 1 AED.~* Patient should have confirmed epilepsy for a minimum of 2 years.~* Patient's AED regimen is stable for at least 1 month prior to enrolment.~* Patient has at least 1 objective partial onset seizure per month during the 2 months prior to enrolment.~* Patient or legal guardian understands study procedures and has voluntarily signed an informed consent in accordance with institutional and local regulatory policies.~Exclusion Criteria:~* Patient has pseudoseizures or a history of pseudoseizures.~* Patient has idiopathic generalised epilepsy or unclassified epilepsy.~* Patient has ever received direct brain stimulation (cerebella or thalamic) for treatment of epilepsy.~* Patient has had a unilateral or bilateral cervical vagotomy.~* Patient has a history of non-compliance with the completion of a seizure diary.~* Patient has taken an investigational drug within a period of 3 months prior to inclusion.~* Patient is currently using another investigational medical device.~* Patient has a significant cardiac or pulmonary condition currently under treatment.~* Patient has previously undergone brain surgery.~* Patient has a demand cardiac pacemaker, implantable defibrillator, or other implantable stimulator.~* Patient currently lives more than 2 hours from the study site or plans to relocate to a location more than 2 hours from the study site within one year of enrolment in the Study.

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- VNS Therapy (Type: EXPERIMENTAL): VNS Therapy + Best Medical Practice
- Best Medical Practice (Type: ACTIVE_COMPARATOR): Best Medical Practice

Based on this trial design, predict the completion outcome and termination type (if applicable).